Johnson & Johnson seals biggest European pharma deal in 13 years as it snaps up Actelion
Telegraph Media Group | January 26, 2017
Johnson & Johnson is buying blood pressure specialist Actelion in an all-cash deal that values the company at $30bn (£23.8bn), following months of complex negotiation and marking the first big pharmaceuticals transaction of the year.